Skip to main content
Clinical Trials/NCT02330172
NCT02330172CompletedNot Applicable

Comparison Sugammadex With Neostigmine in Laryngeal Microsurgery.

Seoul National University Hospital1 site in 1 country44 target enrollmentStarted: May 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
44
Locations
1
Primary Endpoint
Laryngoscopic Score

Study Overview

Brief Summary

This study aims to make a comparison of surgical condition and recovery time between rocuronium 0.45 mg/kg and neostigmine group and rocuronium 0.9 mg/kg and sugammadex group.

Detailed Description

This study aims to make a comparison of surgical condition and recovery time between moderate neuromuscular bloackade with reversal using neostigmine group and deep neuromuscular bloackade with reversal using sugammadex group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
19 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •American Society of Anesthesiologist Physical status classification 1 or 2 elective laryngeal microsurgery under general anesthesia

Exclusion Criteria

  • •BMI >25 or < 20 kg/m2 Patients taking intercurrent medication Glutamic Oxalacetate Transaminase or Glutamic Pyruvate Transaminase > 40 IU/L, Cr > 1.4 mg/dl

Arms & Interventions

rocuronium 0.45 - neostigmine

Active Comparator

when anesthetic induction, inrocuronium 0.45 mg/kg will be administered for muscle relaxation.

When the end of operation, a injection of neostigmine or sugammadex will be administered.

Intervention: Injection of neostigmine or sugammadex (Other)

rocuronium 0.9 - sugammadex

Active Comparator

When anesthetic induction, rocuronium 0.9 mg/kg will be injected to rocuronium 0.9 - sugammadex group for muscle relaxation.

When the end of operation,, a injection of neostigmine or sugammadex be administered.

Intervention: Injection of neostigmine or sugammadex (Other)

Outcomes

Primary Outcomes

Laryngoscopic Score

Time Frame: At the beginning of surgery, the surgeon rated the laryngoscopy condition

Definitions for evaluation of Laryngoscopycondition. : Easy = jaw relaxed, no resistance to blade insertion, fair = jaw not fully relaxed, slight resistance to blade insertion, difficult = poor jaw relaxation, active resistance of the patient to laryngoscopy. Variables Excellent Good Poor

Secondary Outcomes

  • Recovery Time From Neuromuscular Blockade(from the injection of neostigmine or sugammadex up to 30 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials